Pending legislation misses the mark when targeting drug costs
As a Minnesota pharmaceutical company focused on making generic medications, Upsher-Smith’s mission is to provide America’s patients with high quality generic medication options that are cost effective. ... Read More
Maple Grove, MN – April 13, 2023 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced it has expanded its ophthalmic portfolio with the launch of Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, an AB-rated generic ... Read More
Maple Grove, MN – April 11, 2023 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that Becky Jansen, Associate Vice President of Technical Services was recognized as a 2023 Notable Woman in STEM by Twin Cities ... Read More
Maple Grove, MN – April 3, 2023 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Fluphenazine Hydrochloride Tablets, USP in 1 mg, 2.5 mg, 5 mg, and 10 mg strengths. The fluphenazine hydrochloride ... Read More
Maple Grove, MN – March 13, 2023 – Upsher-Smith Laboratories, LLC (Upsher-Smith) was one of six Minnesota manufacturers recognized by Twin Cities Business as a 2023 recipient of its Manufacturing Excellence Award. All the honorees ... Read More
Maple Grove, MN – March 6, 2023 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Dicyclomine Hydrochloride Tablets, USP 20 mg. This product launch is a result of Upsher-Smith’s strategic partnership with CorePharma ... Read More
Maple Grove, MN – February 16, 2023 – Upsher-Smith Laboratories, LLC (Upsher-Smith) and the National Alliance of State Pharmacy Associations (NASPA) are pleased to recognize 47 pharmacists from across the country with the 2022 NASPA ... Read More